PRAX
Common StockPraxis Precision Medicines, Inc.
Reported Shares
84.2K
Position Mix
No options reported
Reported Value
$24.5M
Portfolio Weight
18.63%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$131.6M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
PRAX
Common StockPraxis Precision Medicines, Inc.
Reported Shares
84.2K
Position Mix
No options reported
Reported Value
$24.5M
Portfolio Weight
18.63%
WHWK
Common StockWhitehawk Therapeutics, Inc.
Reported Shares
4.7M
Position Mix
No options reported
Reported Value
$17.6M
Portfolio Weight
13.39%
TNGX
Common StockTango Therapeutics, Inc.
Reported Shares
409.5K
Position Mix
No options reported
Reported Value
$10.2M
Portfolio Weight
7.76%
FDMT
Common Stock4D Molecular Therapeutics, Inc.
Reported Shares
535.1K
Position Mix
No options reported
Reported Value
$7.7M
Portfolio Weight
5.82%
ARGX
Depositary ReceiptARGENX SE
Reported Shares
5.6K
Position Mix
No options reported
Reported Value
$5.3M
Portfolio Weight
4.05%
AVBP
Common StockArriVent BioPharma, Inc.
Reported Shares
170.9K
Position Mix
No options reported
Reported Value
$5.2M
Portfolio Weight
3.93%
SRZN
Common StockSurrozen, Inc./DE
Reported Shares
152.5K
Position Mix
No options reported
Reported Value
$4.9M
Portfolio Weight
3.73%
VOGX
Common StockVogenx, Inc.
Reported Shares
213.2K
Position Mix
No options reported
Reported Value
$4.9M
Portfolio Weight
3.69%
DRUG
Common StockBRIGHT MINDS BIOSCIENCES INC.
Reported Shares
93.2K
Position Mix
No options reported
Reported Value
$4.6M
Portfolio Weight
3.53%
OCUL
Common StockOCULAR THERAPEUTIX, INC
Reported Shares
574.5K
Position Mix
No options reported
Reported Value
$4.4M
Portfolio Weight
3.35%
SLN
Depositary ReceiptSilence Therapeutics plc
Reported Shares
393.6K
Position Mix
No options reported
Reported Value
$4.3M
Portfolio Weight
3.27%
TSHA
Common StockTaysha Gene Therapies, Inc.
Reported Shares
691.8K
Position Mix
No options reported
Reported Value
$3.4M
Portfolio Weight
2.56%
AVLN
Common StockAvalyn Pharma Inc.
Reported Shares
114.7K
Position Mix
No options reported
Reported Value
$3.3M
Portfolio Weight
2.48%
AVTX
Common StockAvalo Therapeutics, Inc.
Reported Shares
186.3K
Position Mix
No options reported
Reported Value
$2.9M
Portfolio Weight
2.17%
MLTX
Common StockMoonLake Immunotherapeutics
Reported Shares
216.6K
Position Mix
No options reported
Reported Value
$2.5M
Portfolio Weight
1.93%
IRD
Common StockOpus Genetics, Inc.
Reported Shares
514.1K
Position Mix
No options reported
Reported Value
$2.5M
Portfolio Weight
1.89%
NERV
Common StockMinerva Neurosciences, Inc.
Reported Shares
729.5K
Position Mix
No options reported
Reported Value
$2.4M
Portfolio Weight
1.86%
LBRX
Common StockLB PHARMACEUTICALS INC
Reported Shares
52.7K
Position Mix
No options reported
Reported Value
$2.0M
Portfolio Weight
1.54%
ACAD
Common StockACADIA PHARMACEUTICALS INC
Reported Shares
0
Position Mix
Reported Value
$2.0M
Portfolio Weight
1.53%
ARTV
Common StockArtiva Biotherapeutics, Inc.
Reported Shares
260.4K
Position Mix
No options reported
Reported Value
$1.9M
Portfolio Weight
1.41%